Abstract
Radioligand therapy in patients with unknown point of origin, other than gastroenteropancreatic or G3 grading neuroendocrine neoplasms
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1530/endoabs.99.ep265
Copy DOIJournal: Endocrine Abstracts | Publication Date: May 6, 2024 |
Radioligand therapy in patients with unknown point of origin, other than gastroenteropancreatic or G3 grading neuroendocrine neoplasms
Join us for a 30 min session where you can share your feedback and ask us any queries you have